Trial Profile
Functional and morphological retinal changes in diabetic macular edema treated with pegaptanib.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 Oct 2013
Price :
$35
*
At a glance
- Drugs Pegaptanib (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 31 Oct 2011 New trial record